Please enable JavaScript
Powered by Benchmark Saransh Kanaujia, Author at Matribhumi Samachar English - Page 1219 of 2944
Friday, April 24 2026 | 05:48:51 AM
Home / Saransh Kanaujia (page 1219)

Saransh Kanaujia

Saransh Kanaujia is currently editor of Matribhumi Samachar Group. He earlier worked with Hindusthan Samachar News Agency. He is also associated with many organizations.

Lion Rock Resources Reports Results from High-Resolution Magnetic Survey and 3D Inversion at Volney Project, South Dakota

Vancouver, British Columbia–(Newsfile Corp. – August 11, 2025) – Lion Rock Resources Inc. (TSXV: ROAR) (FSE: KGB) (OTCQB: LRRIF) (the “Company“) is pleased to announce results from a recent high-resolution UAV magnetic survey (“exMAG“) and advanced 3D inversion at the Volney Project. The exMag results enhance Lion Rock’s current geological …

Read More »

Cardiol Therapeutics to Participate in Fireside Chat at Canaccord Genuity’s 45th Annual Growth Conference

Toronto, Ontario–(Newsfile Corp. – August 11, 2025) – Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) (“Cardiol” or the “Company“), a clinical-stage life sciences company focused on developing anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease, is pleased to announce that it will participate in a Fireside Chat at …

Read More »

Additional $1.83M Received by Great Pacific Gold on Australian Asset Sales

Vancouver, British Columbia–(Newsfile Corp. – August 11, 2025) – Great Pacific Gold Corp. (TSXV: GPAC) (OTCQX: FSXLF) (FSE: V3H) (“Great Pacific Gold,” “GPAC,” or the “Company”) is providing an update on its Victoria, Australia asset divestitures. All dollar figures in this release are Canadian dollars unless otherwise specified (AUD = Australian dollars). …

Read More »

Entero Therapeutics, Inc. Announces $3.0 Million Private Placement Priced at the Market Under Nasdaq Rules

Boca Raton, Florida–(Newsfile Corp. – August 11, 2025) – Entero Therapeutics, Inc. (NASDAQ: ENTO) (the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, today announced that it has entered into definitive agreements with institutional investors for the purchase and sale of …

Read More »

Vext to Announce Financial Results for Q2 2025 on August 20, 2025

Vancouver, British Columbia–(Newsfile Corp. – August 11, 2025) – Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) (“Vext” or the “Company“), a U.S.-based cannabis operator with vertical operations in Arizona and Ohio, today announced that it plans to release its financial results for the second quarter ended June 30, 2025, before market …

Read More »

BioHarvest Sciences Reports Second Quarter 2025 Financial Results

Robust 41% Year-Over-Year Revenue Growth, Driven by Strong Core Capsule and New Product Sales Rehovot, Israel–(Newsfile Corp. – August 11, 2025) – BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) (“BioHarvest” or the “Company”), a company pioneering its patented Botanical Synthesis technology platform, today reported its financial and operational results for …

Read More »

Founders Metals Expands High-Grade Gold Zone at Upper Antino with 46.0 m of 3.59 g/t Au & Deep Drilling Extends Mineralization to 500 m Vertical Depth

Vancouver, British Columbia–(Newsfile Corp. – August 11, 2025) – Founders Metals Inc. (TSXV: FDR) (OTCQX: FDMIF) (FSE: 9DL0) (“Founders” or the “Company”) announces drill core assay results from its ongoing, fully funded 60,000 metre drilling campaign at the Antino Gold Project in southeastern Suriname (Figure 1). Colin Padget, President and …

Read More »